Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on Radiation Therapy Oncology Group clinical trials (Q40762597)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on Radiation Therapy Oncology Group clinical trials	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on Radiation Therapy Oncology Group clinical trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

adaptive radiation therapy

0 references

author name string

Roach M

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Lu J

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Pilepich MV

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Asbell SO

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Mohiuddin M

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Terry R

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Grignon D

7

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

language of work or name

0 references

publication date

1 June 2000

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

609-615

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900578-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900578-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Time to second prostate-specific antigen failure is a surrogate endpoint for prostate cancer death in a prospective trial of therapy for localized disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900578-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of radiotherapeutic parameters and treatment related morbidity--analysis of RTOG Study 77-06

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900578-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in carcinoma of the prostate--analysis of RTOG study 75-06

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900578-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900578-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900578-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Proportional hazards and recursive partitioning and amalgamation analyses of the Southwest Oncology Group node-positive adjuvant CMFVP breast cancer data base: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900578-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Retropubic Implantation of Iodine 125 in the Treatment of Prostatic Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900578-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis of Patients With Stage D1 Prostatic Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900578-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Implications of volume of nodal metastasis in patients with adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900578-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Formula to Estimate Risk of Pelvic Lymph Node Metastasis from the Total Gleason Score for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900578-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The New American Joint Committee on Cancer and International Union Against Cancer TNM classification of prostate cancer. Clinicopathologic correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900578-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900578-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900578-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Conformal technique dose escalation for prostate cancer: Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen ≥10 ng/ml

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900578-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy for high grade clinically localized adenocarcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900578-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of conservative management of clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900578-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Population-based study of long-term survival in patients with clinically localised prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900578-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900578-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(00)00578-2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40762597&oldid=1906760030"